» Articles » PMID: 12220187

RNA Methyltransferases Utilize Two Cysteine Residues in the Formation of 5-methylcytosine

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2002 Sep 11
PMID 12220187
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Proteins that have sequence homology with known RNA m(5)C methyltransferases contain two conserved cysteines, each of which lies within a sequence that bears similarity to a methyltransferase active site. Other enzymes that transfer a methyl group to carbon 5 of a pyrimidine nucleotide, such as the bacterial DNA m(5)C methyltransferases, utilize their single conserved cysteine residue to form a covalent Michael adduct with carbon 6 of the pyrimidine ring during catalysis. We present a model for the utilization of two cysteines in catalysis by RNA m(5)C methyltransferases. It is proposed that one thiol acts in a classical fashion by forming a covalent link to carbon 6 of the pyrimidine base, while the other cysteine assists breakdown of the covalent adduct. Therefore, alteration of the assisting cysteine is anticipated to stabilize the covalent enzyme-RNA intermediate. The model was conceived as a possible explanation for the effects of mutations that change the conserved cysteines in Nop2p, an apparent RNA m(5)C methyltransferase that is essential for ribosome assembly and yeast viability. Evidence for the predicted accumulation of protein-RNA complexes following mutation of the assisting cysteine has been obtained with Nop2p and a known tRNA m(5)C methyltransferase called Ncl1p (Trm4).

Citing Articles

Nsun2 controls cardiac homeostasis and hypertrophic response by regulating PRKACA expression.

Jian D, Cheng X, Qi D, Wang S, Wang C, Shi Y Theranostics. 2025; 15(6):2393-2412.

PMID: 39990213 PMC: 11840729. DOI: 10.7150/thno.104441.


Narrative review of research progress of RNA mC methylation in head and neck malignancies.

Cheng L, Wang C, Zhao D, Wu S Transl Cancer Res. 2024; 13(9):5112-5122.

PMID: 39430837 PMC: 11483327. DOI: 10.21037/tcr-24-103.


RNA 5-Methylcytosine Modification: Regulatory Molecules, Biological Functions, and Human Diseases.

Lu Y, Yang L, Feng Q, Liu Y, Sun X, Liu D Genomics Proteomics Bioinformatics. 2024; 22(5).

PMID: 39340806 PMC: 11634542. DOI: 10.1093/gpbjnl/qzae063.


Methylation modifications in tRNA and associated disorders: Current research and potential therapeutic targets.

Wu Z, Zhou R, Li B, Cao M, Wang W, Li X Cell Prolif. 2024; 57(9):e13692.

PMID: 38943267 PMC: 11503269. DOI: 10.1111/cpr.13692.


Dynamic RNA methylation modifications and their regulatory role in mammalian development and diseases.

Yang W, Zhao Y, Yang Y Sci China Life Sci. 2024; 67(10):2084-2104.

PMID: 38833084 DOI: 10.1007/s11427-023-2526-2.